Jentadueto 2.5 mg/1 (Linagliptin and Metformin Hydrochloride TABLET, FILM COATED) 2.5 mg/1

Jentadueto 2.5 mg/1 combines linagliptin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Strength

2.5 mg/1

Pack Size

180 TABLET, FILM COATED in 1 BOTTLE (0597-0148-18)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Jentadueto 2.5 mg/1 is used to help manage type 2 diabetes by improving blood sugar levels. It is often prescribed alongside diet and exercise to support overall diabetes care. This medication is designed for adults who need dual-action therapy to maintain glycemic control.

Side Effects

Common effects of Jentadueto 2.5 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea. Some users may also experience headaches or low blood sugar, especially when starting the medication or adjusting the dosage.

Precautions & Warnings

Jentadueto 2.5 mg/1 should be used with caution in individuals with kidney or liver issues. It is important to follow the prescribed dosage and consult a healthcare provider before starting this medication, particularly if you have a history of metabolic conditions.

Avoid Interactions

Jentadueto 2.5 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol consumption should be limited, as it can affect blood sugar levels and increase the risk of side effects.

Frequently Asked Questions

Jentadueto 2.5 mg/1 is used to manage type 2 diabetes by improving blood sugar control.

Jentadueto 2.5 mg/1 is taken orally, typically with meals, as prescribed by a healthcare provider.

Common side effects may include gastrointestinal discomfort, headaches, and low blood sugar.

Jentadueto 2.5 mg/1 may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Jentadueto 2.5 mg/1 should be used with caution in individuals with kidney or liver issues, and a healthcare provider should be consulted before starting the medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.